EL219

· Elion Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EL219, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections [Phase 2]